News
11-14-2011, 03:22 AM
Amplification of anaplastic lymphoma kinase, which has been reported in other cancers such as non-small cell lung cancers, may be a primary driver of the rapid metastasis that patients with inflammatory breast cancer experience. If validated, the use of anaplastic lymphoma kinase (ALK) inhibitors may be a new treatment approach for patients with this lethal form of breast cancer...
More... (http://www.medicalnewstoday.com/releases/237595.php)
More... (http://www.medicalnewstoday.com/releases/237595.php)